1. Apoptosis Cell Cycle/DNA Damage
  2. Apoptosis Checkpoint Kinase (Chk) CDK DNA/RNA Synthesis Bcl-2 Family Caspase
  3. Apoptosis inducer 49

Apoptosis inducer 49 is a selective apoptosis inducer with high specificity against CCRF-CEM leukemia cells (IC50 = 2.68 μM). Apoptosis inducer 49 enhances RNA synthesis and replication stress, activates the Chk1-p21 axis, leading to S-phase arrest. Apoptosis inducer 49 can inhibit Bcl-2 and activate caspase-3. Apoptosis inducer 49 can be used for the study of Leukemia.

For research use only. We do not sell to patients.

Apoptosis inducer 49

Apoptosis inducer 49 Chemical Structure

Size Stock
50 mg   Get quote  
100 mg   Get quote  
250 mg   Get quote  

* Please select Quantity before adding items.

This product is a controlled substance and not for sale in your territory.

Top Publications Citing Use of Products
  • Biological Activity

  • Purity & Documentation

  • References

  • Customer Review

Description

Apoptosis inducer 49 is a selective apoptosis inducer with high specificity against CCRF-CEM leukemia cells (IC50 = 2.68 μM). Apoptosis inducer 49 enhances RNA synthesis and replication stress, activates the Chk1-p21 axis, leading to S-phase arrest. Apoptosis inducer 49 can inhibit Bcl-2 and activate caspase-3. Apoptosis inducer 49 can be used for the study of Leukemia[1].

In Vitro

Apoptosis inducer 49 (Compound 16j) exhibits potent cytotoxicity against CCRF-CEM cells (IC50 = 2.68 μM), shows no significant activity against other cancer cell lines and non-cancer cell lines (IC50 > 50 μM), and the therapeutic index (TI) is 18.66[1].
Apoptosis inducer 49 (2.68-13.4 μM, 24 h) demonstrates a dose-dependent increase in the proportion of apoptotic cells and induces significant S-phase arrest in CCRF-CEM cells, where at 2.68 μM, early apoptotic (annexin V+/PI-) cells significantly increase concurrently with a rise in S-phase cells and a decrease in G1 and G2/M populations, while at 13.4 μM, late apoptotic (annexin V+/PI+) cells further accumulate and the S-phase arrest effect becomes more pronounced[1].
Apoptosis inducer 49 (2.68-13.4 μM, 24 h) shows dose-dependent inhibition of DNA replication (nearly complete inhibition at 13.4 μM), but RNA synthesis is enhanced, especially at 13.4 μM in CCRF-CEM cells[1].
Apoptosis inducer 49 (2.68-13.4 μM, 24 h) shifts the cell population toward the P3 region (high red/green fluorescence) in CCRF-CEM cells, indicating mitochondrial hyperpolarization (increased ΔΨm) rather than typical apoptosis-associated depolarization[1].
Apoptosis inducer 49 (2.68-13.4 μM, 24 h) induces DNA damage and replication stress, activates the Chk1-p21 axis leading to S-phase arrest, and triggers apoptosis via the mitochondrial pathway (Bcl-2 inhibition and caspase-3 activation) in CCRF-CEM cells[1].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

Apoptosis Analysis[1]

Cell Line: CCRF-CEM cells
Concentration: 2.68 μM, 13.4 μM
Incubation Time: 24 h
Result: At 2.68 μM, early apoptotic (annexin V+/PI-) cells significantly increased.
At 13.4 μM, late apoptotic (annexin V+/PI+) cells further accumulated.
PI single-positive cells (necrosis markers) were extremely rare.

Western Blot Analysis[1]

Cell Line: CCRF-CEM cells
Concentration: 2.68 μM, 13.4 μM
Incubation Time: 24 h
Result: Caused a moderate increase in Cyclin A expression at both concentrations.
Total Chk1 levels remained stable or slightly elevated at 2.68 μM, while phospho-Chk1 (Ser345), a canonical marker of ATR-mediated replication checkpoint activation, was robustly induced at both 2.68 μM and 13.4 μM.
P21 expression was strongly induced at 2.68 μM.
Induced γH2AX at both concentrations.
Bcl-2 expression was diminished at 13.4 μM.
Caspase-3 was clearly diminished at high concentrations.

Cell Cycle Analysis[1]

Cell Line: CCRF-CEM cells
Concentration: 2.68 μM, 13.4 μM
Incubation Time: 24 h
Result: Caused significant S-phase arrest, at 2.68 μM, the proportion of cells in S phase increased, and the G1 and G2/M populations decreased; the effect was more pronounced at 13.4 μM.
Molecular Weight

575.82

Formula

C36H53N3O3

SMILES

CC1(C)[C@@H](O)CC[C@]2(C)[C@@]3([H])CC[C@]4([H])[C@@]5([H])[C@H](C(C6=CN(CC7=CC=CO7)N=N6)=C)CC[C@@](CO)5CC[C@](C)4[C@@](C)3CC[C@@]12[H]

Shipping

Room temperature in continental US; may vary elsewhere.

Storage

Please store the product under the recommended conditions in the Certificate of Analysis.

Purity & Documentation
References
  • No file chosen (Maximum size is: 1024 Kb)
  • If you have published this work, please enter the PubMed ID.
  • Your name will appear on the site.
  • Molarity Calculator

  • Dilution Calculator

The molarity calculator equation

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

Mass   Concentration   Volume   Molecular Weight *
= × ×

The dilution calculator equation

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
× = ×
C1   V1   C2   V2
Help & FAQs
  • Do most proteins show cross-species activity?

    Species cross-reactivity must be investigated individually for each product. Many human cytokines will produce a nice response in mouse cell lines, and many mouse proteins will show activity on human cells. Other proteins may have a lower specific activity when used in the opposite species.

Your Recently Viewed Products:

Inquiry Online

Your information is safe with us. * Required Fields.

Product Name

 

Requested Quantity *

Applicant Name *

 

Salutation

Email Address *

 

Phone Number *

Department

 

Organization Name *

City

State

Country or Region *

     

Remarks

Bulk Inquiry

Inquiry Information

Product Name:
Apoptosis inducer 49
Cat. No.:
HY-178940
Quantity:
MCE Japan Authorized Agent: